Literature DB >> 30010039

Use of modified U1 small nuclear RNA for rescue from exon 7 skipping caused by 5'-splice site mutation of human cathepsin A gene.

Naoshi Yamazaki1, Keisuke Kanazawa2, Maria Kimura2, Hironobu Ike3, Makiko Shinomiya2, Shouko Tanaka2, Yasuo Shinohara4, Noriaki Minakawa5, Kohji Itoh5, Yoshiharu Takiguchi5.   

Abstract

Cathepsin A (CTSA) is a multifunctional lysosomal enzyme, and its hereditary defect causes an autosomal recessive disorder called galactosialidosis. In a certain number of galactosialidosis patients, a base substitution from adenine to guanine is observed at the +3 position of the 7th intron (IVS7 +3a>g) of the CTSA gene. With this mutation, a splicing error occurs; and consequently mRNA lacking the 7th exon is produced. This skipping of exon 7 causes a frame shift of the transcripts, resulting in a non-functional CTSA protein and hence galactosialidosis. This mutation seems to make the interaction between the 5'-splice site of intron 7 of pre-mRNA and U1 small nuclear RNA (U1 snRNA) much weaker. In the present study, to produce properly spliced mRNA from the CTSA gene harboring this IVS7 +3a>g mutation, we examined the possible usefulness of modified U1 snRNA that could interact with the mutated 5'-splice site. Toward this goal, we first prepared a model system using a mutant CTSA mini gene plasmid for delivery into HeLa cells. Then, we examined the effectiveness of modified U1 snRNA on the formation of properly spliced mRNA from this mutant CTSA mini gene. As a result, we succeeded in obtaining improved formation of properly spliced CTSA mRNA. Our results suggest the usefulness of modified U1 snRNA for rescue from exon 7 skipping caused by the IVS7 +3a>g mutation of the CTSA gene.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exon skipping; Galactosialidosis; RNA splicing; Splice defect

Mesh:

Substances:

Year:  2018        PMID: 30010039     DOI: 10.1016/j.gene.2018.07.030

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

Review 1.  Heritable and non-heritable uncommon causes of stroke.

Authors:  A Bersano; M Kraemer; A Burlina; M Mancuso; J Finsterer; S Sacco; C Salvarani; L Caputi; H Chabriat; S Lesnik Oberstein; A Federico; E Tournier Lasserve; D Hunt; M Dichgans; M Arnold; S Debette; H S Markus
Journal:  J Neurol       Date:  2020-04-21       Impact factor: 4.849

2.  A Reporter Based Cellular Assay for Monitoring Splicing Efficiency.

Authors:  Jason Wong; William Martelly; Shalini Sharma
Journal:  J Vis Exp       Date:  2021-09-15       Impact factor: 1.424

3.  U5 snRNA Interactions With Exons Ensure Splicing Precision.

Authors:  Olga V Artemyeva-Isman; Andrew C G Porter
Journal:  Front Genet       Date:  2021-07-02       Impact factor: 4.599

4.  OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spfash mice, and govern susceptibility to RNA-based therapies.

Authors:  Claudia Sacchetto; Laura Peretto; Mirko Pinotti; Dario Balestra; Francisco Baralle; Iva Maestri; Francesca Tassi; Francesco Bernardi; Stan F J van de Graaf; Franco Pagani
Journal:  Mol Med       Date:  2021-12-14       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.